Literature DB >> 16840508

Colorectal cancer: a model for epigenetic tumorigenesis.

J J L Wong1, N J Hawkins, R L Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16840508      PMCID： PMC1856668          DOI： 10.1136/gut.2005.088799

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  139 in total

1.  DNA methyltransferase Dnmt1 associates with histone deacetylase activity.

Authors:  F Fuks; W A Burgers; A Brehm; L Hughes-Davies; T Kouzarides
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  Nonmethylated transposable elements and methylated genes in a chordate genome.

Authors:  M W Simmen; S Leitgeb; J Charlton; S J Jones; B R Harris; V H Clark; A Bird
Journal:  Science       Date:  1999-02-19       Impact factor: 47.728

Review 3.  Systematic review of microsatellite instability and colorectal cancer prognosis.

Authors:  S Popat; R Hubner; R S Houlston
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

4.  Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome.

Authors:  M Esteller; E Avizienyte; P G Corn; R A Lothe; S B Baylin; L A Aaltonen; J G Herman
Journal:  Oncogene       Date:  2000-01-06       Impact factor: 9.867

5.  Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.

Authors:  P G Corn; S J Kuerbitz; M M van Noesel; M Esteller; N Compitello; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

6.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps.

Authors:  Zsolt Petko; Mahan Ghiassi; Anthony Shuber; Janice Gorham; Walter Smalley; M Kay Washington; Stephen Schultenover; Shiva Gautam; Sanford D Markowitz; William M Grady
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

8.  Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors.

Authors:  Naoto Sakamoto; Takeshi Terai; Yoichi Ajioka; Satoshi Abe; Osamu Kobayasi; Shu Hirai; Okio Hino; Hidenobu Watanabe; Nobuhiro Sato; Tadakazu Shimoda; Hiroaki Fujii
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

Review 9.  CpG island methylator phenotype in cancer.

Authors:  Jean-Pierre Issa
Journal:  Nat Rev Cancer       Date:  2004-12       Impact factor: 60.716

10.  Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.

Authors:  Frank Weber; Micheala A Aldred; Carl D Morrison; Christoph Plass; Andrea Frilling; Christoph E Broelsch; Kristin A Waite; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2004-11-16       Impact factor: 5.958
View more
  65 in total

1.  Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.

Authors:  T Chile; M L Corrêa-Giannella; M A H Z Fortes; M D Bronstein; M B Cunha-Neto; D Giannella-Neto; R R Giorgi
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

Review 2.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

Review 3.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

4.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Authors:  Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Takako Kawasaki; Jeffrey A Meyerhardt; Massimo Loda; Edward L Giovannucci; Charles S Fuchs
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

Review 5.  Chapter 5. Nuclear actin-related proteins in epigenetic control.

Authors:  Richard B Meagher; Muthugapatti K Kandasamy; Elizabeth C McKinney; Eileen Roy
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

6.  Diet and epigenetics in colon cancer.

Authors:  Minna Nystrom; Marja Mutanen
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

7.  Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.

Authors:  Valérie Gratio; Nathalie Beaufort; Lina Seiz; Josefine Maier; G Duke Virca; Mekdes Debela; Nicolai Grebenchtchikov; Viktor Magdolen; Dalila Darmoul
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

8.  Heterocyclic aromatic amine pesticide use and human cancer risk: results from the U.S. Agricultural Health Study.

Authors:  Stella Koutros; Charles F Lynch; Xiaomei Ma; Won Jin Lee; Jane A Hoppin; Carol H Christensen; Gabriella Andreotti; Laura Beane Freeman; Jennifer A Rusiecki; Lifang Hou; Dale P Sandler; Michael C R Alavanja
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

9.  Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.

Authors:  Yoshifumi Baba; Curtis Huttenhower; Katsuhiko Nosho; Noriko Tanaka; Kaori Shima; Aditi Hazra; Eva S Schernhammer; David J Hunter; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Mol Cancer       Date:  2010-05-27       Impact factor: 27.401

10.  Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms.

Authors:  Laura A E Hughes; Piet A van den Brandt; Adriaan P de Bruïne; Kim A D Wouters; Sarah Hulsmans; Angela Spiertz; R Alexandra Goldbohm; Anton F P M de Goeij; James G Herman; Matty P Weijenberg; Manon van Engeland
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.